Your Basket 0
Insight Biotechnology Ltd reserves the right to change pricing without notice
Figure 2: Enriched splenic B-cells prepared by treatment of Lympholyte-M purified spleen lymphocytes with Monoclonal Anti-Thy 1.2 Antibody plus complement, followed by removal of dead cells on Lympholyte-M.